Literature DB >> 7987838

Analysis of the energy balance in lung cancer patients.

A J Staal-van den Brekel1, A M Schols, G P ten Velde, W A Buurman, E F Wouters.   

Abstract

Previous studies have shown that an elevated resting energy expenditure (REE) frequently occurs in lung cancer patients. The aim of the present study was to assess the balance between REE and dietary intake and to analyze the contributing factors of elevated REE in newly detected lung cancer patients. One hundred newly detected lung cancer patients were evaluated. Measured values of REE were adjusted for the values predicted by the Harris-Benedict formula and for fat-free mass assessed by the bioelectrical impedance method. Dietary intake was measured using a dietary history. A substantial number of patients (30%) had a weight loss of 10% or more from their preillness stable weight. An elevated REE was found in 74% of the patients. Stratification by tumor localization revealed that patients with a central tumor had a significantly higher REE [121 +/- 13% (SD) versus 110 +/- 10% of predicted, P < 0.001] and significantly higher level of C-reactive protein (35 +/- 35 mg/liter versus 16 +/- 26 mg/liter, P = 0.006) compared with patients with a peripheral tumor. Dietary intake was significantly lower in the weight-losing group (1872 +/- 542 kcal/day versus 2169 +/- 782 kcal/day, P < 0.05) compared with the weight-stable group. We conclude that both elevated REE and decreased dietary intake contribute to weight loss in lung cancer patients. Tumor localization and inflammation were found to be contributing factors to the elevated REE.

Entities:  

Mesh:

Year:  1994        PMID: 7987838

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

Review 1.  Key determinants of energy expenditure in cancer and implications for clinical practice.

Authors:  S A Purcell; S A Elliott; V E Baracos; Q S C Chu; C M Prado
Journal:  Eur J Clin Nutr       Date:  2016-06-08       Impact factor: 4.016

2.  Metabolism in patients with small cell lung carcinoma compared with patients with non-small cell lung carcinoma and healthy controls.

Authors:  A J Staal-van den Brekel; A M Schols; M A Dentener; G P ten Velde; W A Buurman; E F Wouters
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 3.  Treatment of non-pain-related symptoms.

Authors:  Charles F von Gunten; Ellin Gafford
Journal:  Cancer J       Date:  2013 Sep-Oct       Impact factor: 3.360

4.  Inflammatory cytokines, appetite-regulating hormones, and energy metabolism in patients with gastrointestinal cancer.

Authors:  Ayaka Shinsyu; Shigeki Bamba; Mika Kurihara; Hiroshi Matsumoto; Ayano Sonoda; Osamu Inatomi; Akira Andoh; Katsushi Takebayashi; Masatsugu Kojima; Hiroya Iida; Masaji Tani; Masaya Sasaki
Journal:  Oncol Lett       Date:  2020-05-21       Impact factor: 2.967

5.  Evaluation of nutritional status in advanced metastatic cancer.

Authors:  N Sarhill; F Mahmoud; D Walsh; K A Nelson; S Komurcu; M Davis; S LeGrand; O Abdullah; L Rybicki
Journal:  Support Care Cancer       Date:  2003-08-15       Impact factor: 3.603

Review 6.  Nutritional support in multimodal therapy for cancer cachexia.

Authors:  Ingvar Bosaeus
Journal:  Support Care Cancer       Date:  2008-01-15       Impact factor: 3.603

7.  Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease.

Authors:  A M Schols; W A Buurman; A J Staal van den Brekel; M A Dentener; E F Wouters
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

8.  The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia.

Authors:  R Dallmann; P Weyermann; C Anklin; M Boroff; K Bray-French; B Cardel; I Courdier-Fruh; H Deppe; J Dubach-Powell; M Erb; R H Haefeli; M Henneböhle; H Herzner; M Hufschmid; D L Marks; S Nordhoff; M Papp; C Rummey; G Santos; F Schärer; H Siendt; M Soeberdt; L T Sumanovski; M Terinek; C Mondadori; N Güven; A Feurer
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-08-28       Impact factor: 12.910

9.  The effects of treatment with chemotherapy on energy metabolism and inflammatory mediators in small-cell lung carcinoma.

Authors:  A J Staal-van den Brekel; A M Schols; M A Dentener; G P ten Velde; W A Buurman; E F Wouters
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?

Authors:  P J Ross; S Ashley; A Norton; K Priest; J S Waters; T Eisen; I E Smith; M E R O'Brien
Journal:  Br J Cancer       Date:  2004-05-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.